Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2001, p. 2618-2626, Vol. 39, No. 7
Mayo Clinic, Rochester, Minnesota
Received 16 November 2000/Returned for modification 11 January
2001/Accepted 22 March 2001
We developed a rapid thermocycling, real-time detection (also known
as real-time PCR) method for the detection of Legionella species directly from clinical specimens. This method uses the LightCycler (Roche Molecular Biochemicals, Indianapolis, Ind.) and
requires approximately 1 to 2 h to perform. Both a
Legionella genus PCR assay and Legionella
pneumophila species-specific PCR assay were designed. A total of
43 archived specimens from 35 patients were evaluated, including 19 bronchoalveolar lavage (BAL) specimens and 24 formalin-fixed,
paraffin-embedded open lung biopsy specimens. Twenty-five of the
specimens were culture-positive for Legionella (9 BAL specimens and 16 tissue specimens). BAL specimens were tested by LightCycler PCR
(LC-PCR) methods and by a direct fluorescent antibody (DFA) assay,
which detects L. pneumophila serogroups 1 to 6 and several
other Legionella species. Tissue sections were tested by
the two LC-PCR methods, by DFA, by an in situ hybridization (ISH)
assay, specifically designed to detect L. pneumophila, and
by Warthin-Starry (WS) staining. The results were compared to the
"gold standard" method of bacterial culture. With BAL specimens the
following assays yielded the indicated sensitivities and specificities,
respectively: Legionella genus detection by
Legionella genus LC-PCR, 100 and 100%;
Legionella genus detection by DFA assay, 33 and 100%; and
L. pneumophila detection by L. pneumophila
species-specific LC-PCR, 100 and 100%. With open lung biopsy specimens
the following assays yielded the indicated sensitivities and
specificities, respectively: Legionella genus detection by
LC-PCR 68.8 and 100%; Legionella genus detection by DFA
assay, 44 and 100%; Legionella genus detection by WS
staining, 63 and 100%; L. pneumophila species-specific
detection by LC-PCR, 17 and 100%; and L. pneumophila
species-specific detection by ISH, 100 and 100%. The analytical
sensitivity of both LC-PCR assays was <10 CFU/reaction. LC-PCR is a
reliable method for the direct detection of Legionella
species from BAL specimens. The Legionella genus LC-PCR
assay could be performed initially; if positive, L. pneumophila species-specific LC-PCR could then be performed (if
species differentiation is desired). The speed with which the LC-PCR
procedure can be performed offers significant advantages over both
culture-based methods and conventional PCR techniques. In contrast, for
the methods evaluated, culture was the best for detecting multiple
Legionella species in lung tissue. WS staining, Legionella genus LC-PCR, and L. pneumophila
species-specific ISH were useful as rapid tests with lung tissue.
The genus Legionella,
family Legionellaceae, includes over 40 different species of
fastidious gram-negative bacilli, with over 60 described serogroups
(2, 21, 41, 60). While these organisms represent normal
environmental flora, many have been shown to cause human disease, most
commonly opportunistic pneumonia in immunocompromised patients. The
vast majority of such cases (approximately 85%) are due to L. pneumophila, with a substantial minority due to other species,
most commonly L. micdadei, L. bozemanii, L. dumoffii, and
L. longbeachae (17, 41, 47).
Legionella pneumonia can be community acquired or nosocomial
and sporadic or epidemic in nature. Pulmonary infection may be
subclinical or severe and life threatening. The fatality rate can
approach 50% in immunocompromised patients (60). The
organism often responds to antimicrobial therapy, usually with
macrolides, and clinical responses usually occur within 3 to 5 days.
The latter fact, combined with clinical and radiographic features that
are often nonspecific, serves to underscore the value of a prompt and
accurate laboratory diagnosis.
The diagnosis of Legionella infection can be made from a
number of specimen types and by a number of testing modalities.
Bacterial culture of bronchoscopy or lung biopsy specimens remains the
most sensitive means of detection (7, 11, 61). Specialized
growth medium, such as buffered charcoal-yeast extract agar (BCYE Assays based on molecular diagnostic techniques have included DNA
probes for in situ hybridization (ISH), as well as PCR-based methods.
Probes have largely been directed against rRNA sequences, with
sensitivities of approximately 30 to 75% in both bronchoalveolar lavage (BAL) and fixed tissue specimens (11, 13, 14, 16, 18, 19,
45, 55). PCR methodology has been used primarily against the 5S
and 16S rRNA genes and against the macrophage infectivity potentiator
(mip) gene of L. pneumophila. The latter
amplification assays have been utilized for detection of
Legionella species in environmental specimens, serum, urine,
throat swabs, and BAL specimens (1, 6, 22, 24, 27, 28, 32, 33,
35-38, 40, 42, 46, 49, 53). Several studies have shown 100% sensitivity when such methods are used on BAL specimens. A few investigators have suggested that PCR may exceed culture in its ability
to detect Legionella in these specimens (6, 22, 24, 33). To our knowledge, no studies exist that examine the
sensitivity of these techniques in tissue specimens.
Conventional molecular methods, used in the above-noted studies,
require PCR-based amplification, followed by probe hybridization detection (24). These methods are labor intensive and
frequently require at least 1 day to perform. Additionally, the
required manipulation of postamplification products increases the
risk of carryover contamination and resultant false positivity.
By using commercially available, rapid cycle, real-time PCR
instrumentation (LightCycler; Roche Molecular Biochemicals,
Indianapolis, Ind.), PCR amplification and detection can be combined in
a single closed cuvette, with dramatically reduced cycling time
(58). This method obviates the need for further
manipulation of the specimen, greatly reduces turnaround time, and
diminishes the risk of cross-contamination between samples (54,
57). As recently demonstrated (15, 26, 31, 44, 59),
this and other real-time PCR methods are attractive alternatives to
conventional PCR techniques in the clinical laboratory.
We describe the development of a real-time LightCycler PCR (LC-PCR)
method, for the detection of Legionella species directly from clinical specimens. Both a Legionella genus LC-PCR
assay and an L. pneumophila species-specific LC-PCR assay
were designed. With conventional culture serving as the "gold
standard," the results of LC-PCR were compared to direct fluorescent
antibody (DFA) assay for the detection of Legionella species
in BAL specimens, and to DFA assay, ISH, and WS staining for the
detection of Legionella species in open lung biopsy specimens.
Control organisms.
All experiments to optimize PCR
conditions, as well as dilution studies to evaluate sensitivity and
plasmid construction, were performed using L. pneumophila
serogroup 1 (ATCC 33152). Other strains of Legionella, used
for validation of the assay, are listed in Table
1, and included L. pneumophila
serogroups 1 to 6, as well as several other strains of
Legionella, representing the most commonly isolated
non-L. pneumophila species. The specificity of the assay was
assessed using a panel of control strains of bacteria (Table
2), representing both commonly isolated
respiratory pathogens and nonpathogens that might be detected in
respiratory specimens.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.7.2618-2626.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Direct Detection of Legionella Species from
Bronchoalveolar Lavage and Open Lung Biopsy Specimens: Comparison of
LightCycler PCR, In Situ Hybridization, Direct Fluorescence
Antigen Detection, and Culture

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
), is required, with up to 2 weeks of incubation recommended to ensure maximal recovery (11). Isolates are typically identified
by a combination of colony and Gram stain morphology, with serologic confirmation and species identification, using specific
fluorescein-labeled antibodies. Direct detection of organisms in
uncultured clinical specimens, usually performed with immunofluorescent
methods, is much more rapid than culture, but the sensitivity of these
methods has been reported to be poor (11, 12, 56). A
variety of means, including radioimmunoassay, enzyme immunoassay, and
latex agglutination, can be used to detect a soluble polysaccharide antigen of L. pneumophila (serogroup 1 only), in urine, with
a reported sensitivity of 55 to 90% (8-10, 25, 48, 56).
Serologic methods are highly sensitive (56, 60), but their
utility is generally limited to epidemiologic studies, due to the time
lag needed to detect seroconversion. A number of methods have been used
in attempt to identify these organisms in paraffin-embedded tissue sections, including various histochemical and
immunohistochemical techniques (3-5, 50, 52). Silver
impregnation stains, such as the Warthin-Starry (WS) stain
(39), serve as the current mainstay of detection in such cases.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Control strains of Legionella
TABLE 2.
Specificity panel for Legionella LCR-PCR
assays
Clinical specimens. A retrospective review of positive Legionella culture results at the Mayo Clinic, from 1979 to 1999, revealed nine BAL specimens for which frozen, archived material was available. In seven of these cases, frozen cell suspensions were available; in two cases, only supernatant was available for analysis. In addition, cell suspensions from 10 BAL specimens which were culture-negative for Legionella, were randomly selected from similarly archived material. These cell suspensions were originally prepared from BAL specimens using a cytospin method. Only cell suspensions having >2 × 106 cells counted by microscopy on a 4-mm2 grid were cultured for Legionella spp. and archived. Cultures of BAL or lung biopsy specimens were performed at the time the specimens were collected using standard techniques (43); cultures were not repeated on archived portions of these specimens during the present study. In all cases, archived results of DFA assays for Legionella, performed on fresh specimens, were also available. A retrospective review, also from 1979 to 1999, revealed nine open lung biopsy specimens culture positive for Legionella species, for which a total of 16 formalin-fixed, paraffin-embedded tissue blocks were available for evaluation. Eight open lung biopsy specimens, from the same time period, all showing nonspecific histologic findings of pneumonia or pneumonitis and all culture-negative for Legionella species, were also selected for evaluation. A single tissue block was used from each of these culture-negative cases.
BAL processing and culture methodology.
Prior to culture,
BAL specimens were centrifuged for 15 min at 1,200 × g
and 2,500 rpm, and the top 7.5 ml of the resulting suspension was
removed. The remaining cell concentrate was mixed and used for culture.
Fresh tissue from open lung biopsy specimens was homogenized in
enriched brain heart infusion broth (Difco formulation; Becton
Dickinson, Sparks, Md.) prior to plating. Culture for
Legionella species was performed on BCYE
and BCYE
with
polymyxin B, anisomycin, and vancomycin (Becton Dickinson), and plates
were incubated at 35°C, in room air, for up to 14 days. Organisms
from characteristic colonies were Gram stained and identified to the
species level using a commercially available panel of fluorescein isothiacyanate (FITC)-labeled antibodies (SciMedX, Denville, N.J.).
Histopathologic examination. Tissues stained with hematoxylin and eosin and WS stain were cut and stained concurrent with and consecutive to sections taken for ISH, DFA assay, and PCR. All tissue sections were cut at 4 µm. Hematoxylin and eosin staining and WS staining were carried out using standard histologic laboratory methods (39).
The WS-stained slides were evaluated in a blinded manner by one of the authors (M.C.A.) Slides positive for Legionella-like organisms showed dark-brown-staining bacillary structures (Fig. 1).
|
DFA detection. Prior to direct examination, fresh BAL specimen was centrifuged for 5 min, at 2,500 rpm, and the resultant supernatant was removed (in some cases this supernatant was later used in the PCR assay; see below, under "Real-time PCR"). The cell pellet was resuspended in normal saline, with lysis agent and/or mucolytic agents added as necessary. This cell suspension was used both for DFA assay and PCR (see below). For each smear to be examined by DFA, 200 µl was cytocentrifuged at 700 rpm, for 7 min, onto a clean glass slide and allowed to air dry. Histologic sections were deparaffinized through xylene and graded ethanol dilutions and allowed to air dry prior to examination. DFA assay was performed per the manufacturer's instructions (SciMedX). Two polyvalent FITC-labeled rabbit anti-Legionella conjugate pools were applied to a separate replicate smear or tissue section. FITC-labeled negative rabbit globulin was applied to a third replicate of the specimen, to serve as a negative control. Antibody pools were also applied to a positive control slide prepared from a known Legionella-positive lung tissue specimen in formalin. Positives were interpreted based on the presence of fluorescent bacillary structures in a given smear or section.
ISH. ISH was performed by a procedure, as previously described with some modifications (34).
(i) Oligonucleotide probes.
Two oligonucleotide probes
(Table 3), both directed against the 16S
rRNA sequence of L. pneumophila, were used. One probe was
previously described (19). The other probe was designed based on the analysis of sequence matches and mismatches (GenBank). The
specificity of probes was checked against the sequences of other
bacteria, fungi, parasites, and animals, using Genetics Computer Group
software (Madison, Wis.). Probes were 3' tailed with
digoxigenin-11-dUTP (Enzo Diagnostic, Inc.) and then diluted to a final
concentration of 2.0 ng/µl in hybridization buffer.
|
(ii) Pretreatment of sections for ISH. Paraffin sections, after deparaffinizing and rehydration, were rinsed twice in diethyl pyrocarbonate-treated H2O for 2 min each. Endogenous alkaline phosphatase activity was quenched with 0.2 M HCl for 20 min at room temperature, and slides were microwaved for 10 min in 10 mM citric acid, pH 6.0, and cooled to room temperature. Sections were then digested with proteinase K (25 µg/ml; Sigma, St. Louis, Mo.) in 10 mM phosphate-buffered saline, pH 7.2, for 10 min at room temperature, followed by acetylation for 15 min with freshly prepared 0.6% acetic anhydride in 0.1 M triethanolamine (pH 8.0). Prehybridization was performed for 30 min, at room temperature, with a mixture containing 50% deionized formamide (Sigma), 10% dextran sulfate (Sigma), 1× Denhardt's solution (Sigma), 3× standard saline citrate (SSC), salmon sperm DNA (100 µg/ml, Sigma), yeast tRNA (125 µg/ml), polyadenylic-cytidylic acid (10 µg/ml), Tris (0.05 M), EDTA (5 mM), 600 mM NaCl, and 0.1% sodium pyrophosphate (inorganic).
(iii) Hybridization and post hybridization washes. Following prehybridization, residual prehybridization buffer was thoroughly removed from around the tissue section. An oligonucleotide probe cocktail specific for L. pneumophila (2 ng/µl in prehybridization buffer) was applied to sections. A Sigmacote (Sigma) coverglass was placed on each slide, and the slides were heat treated at 95°C for 5 min and hybridized in a humid environment for 3 h at 50°C. Sections were rinsed twice in 2× SSC for 10 min at room temperature, washed in 0.5× SSC at 37°C for 20 min (to remove excess probe), and rinsed twice in buffer A (1% normal sheep serum in 0.3% Triton X-100) for 2 min at room temperature.
(iv) Immunochemical detection. After posthybridization washing, digoxigenin-labeled probes were detected according to the manufacturer's instructions (digoxigenin detection kit; Boehringer Mannheim). Briefly, after preincubation of sections for 30 min in blocking buffer A (1% normal swine serum and 0.3% Triton X-100), the sections were incubated in a 1:200 dilution of alkaline phosphatase-conjugated antidigoxigenin Fab fragment in blocking buffer A for 1 h at room temperature. Rinsing with buffer A and buffer C (Tris-HCl and MgCl, pH 9.5) was performed, and sections were subsequently reacted with nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolyphosphate (BCIP), forming an insoluble blue precipitate at the site of reaction. Sections were then rinsed in buffer C, counterstained with 0.1% nuclear fast red, rinsed again in buffer C, dehydrated in graded ethanols, and cleared in xylene, and a coverslip was placed on each section with a xylene-based synthetic mounting medium. Positive interpretation of a slide was based on the presence of blue-staining bacillary structures, against a pink-red background (Fig. 1).
(v) ISH negative controls and probe specificity tests. Negative controls used for ISH consisted of (i) omission of the probes from the hybridization reaction; (ii) slides hybridized with nonlabeled probe; (iii) cross-reactivity testing for target specificity, using an ISH probe for albumin, hybridized to Legionella-positive tissue sections; and (iv) cross-reactivity testing for probe specificity, using five additional specimens with tissue involvement by other gram-positive and gram-negative bacteria.
Real-time PCR.
PCR and product detection were performed
simultaneously on LightCycler instrumentation (Roche Molecular
Biochemicals). The LightCycler is a combined thermocycler and
fluorimeter that offers rapid PCR thermocycling (20 to 40 min). The
temperature is controlled with circulated heated and ambient air.
Samples and PCR master mix are contained in 30-µl glass cuvettes
(58). Sample detection is based on the principle of
fluorescence resonance energy transfer (57, 58), with
adjacent hybridization probes directed against the intended PCR
product. With fluorescein serving as the donor fluorophore and LC-Red
640 (Roche Molecular Biochemicals) serving as the acceptor fluorophore,
the presence of PCR amplicons can be assessed by detection of LC-Red
640 fluorescence. Samples can be assayed for the presence of this
signal during each PCR cycle, and the cycle number at which the signal
is first detected can be correlated to the original concentration of
target. The specificity of amplification can be confirmed by melting
curve analysis. Single melting peaks can be generated by depicting the
negative derivative of fluorescence versus temperature (
dF/dT) over
the course of a gradual PCR product melt (see below, "PCR cycling and
melting curve conditions").
(i) Extraction of control bacterial strains. Pure culture isolates, used as control organisms, were extracted by two different methods. (i) In the case of gram-negative isolates, including Legionella species, bacterial colonies were suspended in sterile H2O, to a turbidity of approximately 1 McFarland standard, lysed in a 100°C heat block for 10 min, and centrifuged for 1 min at 20,000 × g. The resulting supernatant was used for analysis. (ii) In the case of gram-positive isolates, bacterial colonies were suspended in 1.0 ml of 1 N NaOH, to a turbidity of approximately 1 McFarland standard and incubated at room temperature for 5 min. The cells were pelleted, washed in an equal volume of 0.5 M Tris-HCl (pH 8.0), pelleted again, and resuspended in 100 µl of H2O. After heating in a 100°C heat block for 10 min, the suspension was centrifuged for 1 min at 20,000 × g, and the supernatant was used for analysis. Control extracts were used at a final dilution of 1:100 in sterile H2O. The presence of amplifiable DNA in specificity controls was verified by utilizing broad-range 16S ribosomal (rDNA) amplification by standard methods (23). Specific PCR assays were used to verify the presence of nucleic acid in extracts of mycobacteria and chlamydiae.
(ii) Extraction of BAL specimens. BAL specimens were extracted using Chelex 100 (InstaGene Matrix; Bio-Rad Laboratories, Hercules, Calif.). Briefly, the specimen was mixed thoroughly, and 20 µl was added to 200 µl of InstaGene matrix. The resulting solution was mixed and placed in a 100°C heat block for 10 min. After mixing again, the sample was centrifuged for 2 min at 12,000 rpm. The resulting supernatant was used for analysis.
(iii) Extraction of tissue specimens. Tissue sections (25 µm thick) were cut consecutively with other sections that were used for DFA and ISH assays. The sections were each cut with a clean blade and placed in a sterile glass tube. Sections were deparaffinized in xylene, washed twice in absolute ethanol, subjected to proteinase K digestion overnight at 55°C, and then placed in a 100°C heat block for 15 min. Extractions were carried out using QIAmp DNA spin columns (Qiagen Inc., Valencia, Calif.), following a standard protocol. DNA was eluted from the spin columns twice, each using 50 µl of elution buffer AE (from the QIAmp DNA mini kit). Elution buffer was incubated in the column for 1 min at room temperature, prior to the first elution, and for 5 min at RT prior to the second elution. The first and second eluants were analyzed separately by PCR.
(iv) Primers and probes. All nucleic acid targets for primers and probes used in the study are listed in Table 3. Amplicons were kept to a minimum length (105 bp for the 5S gene and 124 bp for mip) in order to enhance the utility of these assays in formalin-fixed tissue. Probes were constructed in order to juxtapose donor (fluorescein) and acceptor (LC-Red 640) fluorophore dyes, when probes were annealed to amplicon. The mip primer-probe set was constructed for specific detection of L. pneumophila (Legionella pneumophila species-specific LC-PCR). The 5S rRNA primer-probe set was constructed to allow detection of all common Legionella species (Legionella genus LC-PCR). Primers for the latter assay were slightly truncated versions of the 20-mer sequences, L5SL9 and L5SR93, previously reported by Mahbubani et al. (35). Due to constraints imposed by the size and sequence of the 5S amplicon, only a single probe, a 23-bp portion of the 50-mer probe, also reported by Mahbubani et al. (35) was used. This probe was labeled at its 5' end with LC-Red 640, while the fluorescein label was placed near the 3' end of the reverse primer, for fluorescence resonance energy transfer signal production.
(v) PCR master mix (5S). A 5-µl aliquot of sample (5 µl of H2O was used as a negative control for each run) was added to 15 µl of PCR mix in each sample cuvette. Optimized PCR master mix consisted of 50 mM KCl-20 mM Tris-HCl (pH 8.4) with a 0.1 mM concentration of each of the deoxyribonucleoside triphosphates, 6 mM MgCl2, a 0.5 µM concentration of both 5S primers, a 0.1 µM concentration of the single 5S probe, 0.05% IGEPAL CA-630 (Sigma), 0.025% bovine serum albumin, and 0.025 U of PLATINUM Taq DNA Polymerase (Life Technologies, Rockville, Md.) per µl.
(vi) PCR Master Mix(mip). A 5-µl aliquot of sample (5 µl of H2O was used as a negative control for each run) was added to 15 µl of PCR mix in each sample cuvette. Optimized master mix consisted of 50 mM KCl-20 mM Tris-HCl (pH 8.4) with a 0.2 mM concentration of each of the deoxyribonucleoside triphosphates, 6 mM MgCl2, a 0.5 µM concentration of both mip primers, a 0.2 µM concentration of the fluorescein mip probe, a 0.4 µM concentration of the LC-Red 640 mip probe, 0.05% IGEPAL CA-630 (Sigma), 0.025% bovine serum albumin, and 0.025 U of PLATINUM Taq DNA Polymerase (Life Technologies) per µl.
(vii) PCR cycling and melting curve conditions. PCR reagents and specimen extracts were sealed in glass capillary cuvettes with plastic plugs, centrifuged to allow mixing and to drive the mix into the distal end of each tube, and then placed on the LightCycler instrument. The cycling protocol was identical for both the mip and the 5S amplification reactions: one cycle of 95°C for 2 min followed by 50 cycles of denaturation at 95°C, annealing for 10 s at 57°C, and extension for 5 s at 72°C. Melting curves were generated as follows: starting at 55°C, the thermal chamber temperature was slowly raised to 85°C, during which time fluorescence was measured at frequent intervals. Analysis of PCR amplification and melting curves was carried out using LightCycler software.
(viii) Sensitivity and inhibition studies. The sensitivities of both PCR assays were assessed by testing serial dilutions of a known number of CFU of L. pneumophila. PCR inhibition was assessed by spiking all culture- and PCR-negative eluants of both BAL and tissue specimens with low concentrations of L. pneumophila. Concentrations of organism used were within 1 log unit of each assay's limit of sensitivity. Inhibition was demonstrated by loss of amplification signal and/or by appearance of signal at a later cycle number than that seen in similar concentrations of organisms, diluted in sterile water as a control.
Analysis of results.
For direct (WS, DFA, ISH) assays,
positives were defined by the presence of five or more identifiable
bacilli, with the proper staining characteristics for the given assay
(as defined above). For PCR, positives were defined by a fluorescent
signal from the reporter dye (either during PCR amplification or during
melting curve analysis) of three times the baseline level of
fluorescence (in turn defined by the signal from the negative control
cuvette for each run). The results of culture were considered to be the gold standard against which all other assays were compared. Several tissue isolates were originally designated "Legionnaires' disease bacillus" (LDB), as they were recovered before methods were in use
for species determination. These were all retrospectively classified as
L. pneumophila, based on the results of ISH, for the current
study. Analysis of results was based on the number of specimens, rather
than on the number of cases or patients tested. For BAL fluid samples,
cells and supernatants from a single
lavage procedure were classified as a single specimen. A breakdown of results, by case, as well as by specimen, is given in Tables 4 and
5.
|
|
| |
RESULTS |
|---|
|
|
|---|
Validation of PCR assay on culture isolates. Both Legionella primer-probe sets were tested against a total of 17 different known strains of Legionella (Table 1). All Legionella species and strains were detected by the Legionella genus (5S rDNA) primers and probes, with all L. pneumophila serotypes detected by the L. pneumophila species-specific (mip) primers and probes. Both PCR assays showed 100% specificity (Table 2), with no evidence of cross-reactivity against any of the non-Legionella isolates. Both tests showed an analytic sensitivity of <10 CFU when used with serial dilutions of a known concentration of control organism.
BAL specimens.
As shown in Tables 4 and
6, the 5S rDNA Legionella
genus LC-PCR assay detected nine of nine culture-positive specimens
(100% clinical sensitivity), including two non-L.
pneumophila species (L. bozemanii and L. micdadei). All 10 culture-negative specimens were negative by this
LC-PCR assay (10 of 10; 100% specificity). Similarly, the mip L. pneumophila species-specific PCR assay detected seven of seven
L. pneumophila culture-positive specimens and 12 of 12 specimens were correctly identified as negative for L. pneumophila (100% clinical sensitivity and specificity).
Inhibition studies showed minimal evidence of inhibitory effect for
each of the 10 Legionella-negative extracts, based on the
ability to detect low concentrations of spiked organisms. Results of
inhibition assays were similar for both the 5S rRNA
Legionella genus and the L. pneumophila
species-specific tests. Only three of nine
Legionella-culture-positive specimens were detected by DFA
assay (33% sensitivity and 100% specificity).
|
Open lung biopsy specimens.
Tables 5 and 6 show the results
obtained from open lung biopsy specimens. The method used most commonly
by surgical pathologists, examination of WS-stained slides, showed
positive results in 10 of 16 specimens which were culture-positive for
Legionella species (63% sensitivity); there were no
false-positive stains (100% specificity). The sensitivity and
specificity for the DFA method were 44% (7 of 16 culture-positive
specimens detected) and 100%, respectively. ISH detected all 14 L. pneumophila culture-positive specimens (100% sensitivity
and 100% specificity). As noted previously, the ISH assay was not
designed for detection of non-L. pneumophila species;
therefore, the slides with L. bozemanii were counted as
culture negative for the purposes of this analysis. Specificity controls (see Materials and Methods)
including specimens which were
culture-negative for Legionella, probe-negative assays,
assays performed with nonlabeled probe, and both target and probe
cross-reactivity assays
were all negative.
Turnaround time. Legionella culture, while usually positive in 3 to 5 days, is not reported as negative by our laboratory until a full 2-week incubation period has elapsed. DFA assay of BAL specimens, including BAL prep and cytospin, in our hands requires 1 to 2 h. Similarly, real-time PCR of BAL specimens requires approximately 1 to 2 h, including sample preparation, cycling, and detection. Studies performed on fixed tissue sections require more time, due to the need for overnight tissue processing and paraffin embedding. Including that processing time, WS, DFA, and ISH assays of tissue all require ~24 h for assay turnaround. LC-PCR of tissue required an additional overnight digestion, bringing its reporting time to 2 days.
| |
DISCUSSION |
|---|
|
|
|---|
For many years the gold standard test for diagnosing Legionella infection has been culture. A drawback of culture is that results may not be available for several days. Rapid testing methods, which include direct histochemical staining of tissue, fluorescent antibody staining of tissue or pulmonary secretions, urine antigen detection, and serology, have been useful but often lack sensitivity and/or specificity. Recently, real-time PCR assays have become available which are highly sensitive and can be performed in as little as 1 to 2 h. In the present study, we evaluated the utility of the LC-PCR method for detecting Legionella species in pulmonary tissues and in BAL fluid. We compared this method, along with DFA assay, ISH, and WS staining, to the gold standard culture method.
With BAL specimens, LC-PCR showed a high degree of sensitivity and specificity. These results agree with previous publications, which used conventional nucleic acid amplification methods (22, 24, 28, 29, 53). By using the combination of both 5S rDNA- and mip-directed primer-probe sets, we demonstrated detection of all commonly reported pathogenic species of Legionella and were able to differentiate L. pneumophila. Specificity was demonstrated by testing both culture-negative BAL specimens, and an extensive panel of non-Legionella bacterial isolates. Sensitivity was 100% in clinical specimens, and additional spiking studies showed detection to <10 CFU of Legionella organisms. Inhibition of LC-PCR was minimal, as demonstrated with artificially spiked extracts of Legionella culture-negative BAL specimens. The entire LightCycler assay, including preparation of the BAL specimen, can be easily performed in 1 to 2 h. This compares to the extended incubation periods needed for Legionella cultures. The DFA assay, while requiring a similar time frame for testing, was shown to have a relatively low sensitivity (33%). While a wide range of sensitivities for this assay has been reported (20), the lower number is consistent with the findings of some investigators (11, 12). The DFA assay performed better in paraffin-embedded tissue sections than in BAL specimens. Our results for sensitivity (44%) are slightly lower than those reported by Theaker et al. (51) (six of nine positives detected) and higher that those noted by Koide et al. (29) (two of eight positives detected). In comparison, for the current study examination of WS-stained slides demonstrated a sensitivity of 63%, which is similar to the results obtained in an earlier study using the Dieterle silver impregnation method (4).
We are aware of a single report evaluating the ISH method
(16). This investigation showed ISH to have a sensitivity
of 69%, compared to other methods (culture, DFA assays, and serology), for the identification of Legionella in fixed tissue
specimens (16). The present study demonstrated that both
real-time PCR and ISH were able to detect a majority of cases of
legionellosis. ISH, in this case limited to the detection of L. pneumophila, was positive in all specimens infected by that
species (100% sensitivity). This method has a rapid turnaround time
(roughly 24 h, including tissue processing
same day,
excluding tissue processing). The LC-PCR Legionella genus
assay had a sensitivity of 69% and a specificity 100%; the assay was
able to detect the single patient infected by L. bozemanii.
In contrast, the mip L. pneumophila species-specific PCR
assay performed poorly with tissue sections, with a sensitivity of only
17%.
The lower sensitivity of LC-PCR with tissue specimens, compared to that with BAL specimens, may be explained by several factors. Inhibition of the PCR, either by components of the extraction process, or by substances in tissue specimens, may have played a role. We noted that in the initial 50 µl of eluant from the extraction column, there was significant inhibition of PCR. Inhibition was minimal in the second eluant, suggesting that an inhibitory compound(s) was either diluted or washed through by that point in the procedure. Consistent with this is the fact that more specimens were positive in the second eluant (nine samples positive) than in the first eluant (six samples positive). Unfortunately, while the inhibitory effect may have been reduced, the second eluant also would have a markedly reduced quantity of target DNA. Overall efficiency of the extraction protocol may also be a factor. Additionally, amplification of DNA from fresh tissue samples versus formalin-fixed samples may have resulted in higher sensitivities. No fresh tissue was available for the current study. Formalin fixation may fragment DNA, making fewer targets of acceptable size available for PCR. Moreover, the higher sensitivity of the Legionella 5S rDNA genus assay versus the L. pneumophila mip species-specific assays may also relate to this effect; smaller amplicons were produced with the Legionella 5S rDNA genus assays (105 bp) than with the L. pneumophila mip species-specific assay (124 bp). These factors aside, decreased sensitivity of the mip gene assay compared with the 5S rDNA assay may also be explained by the fact that the mip gene is present as a single copy per genome, as opposed to the 5S rDNA sequence, which may present in multiple copies.
Despite some limitations in sensitivity for detecting Legionella species in tissue specimens, LC-PCR appears to be as sensitive as culture for detecting Legionella species in BAL specimens. While the total number of cases in our study was relatively small, the findings are corroborated by those of several other authors, using conventional PCR methods (22, 24, 28, 29, 53); several of these authors showed PCR to have a higher rate of detection than culture-based methods. The use of real-time PCR increases the ease and practicality with which PCR can be introduced into the clinical laboratory. It also offers a dramatic decrease in turnaround time for results and a marked reduction in the risk of carryover contamination (inherent in single-tube amplification assays).
Molecular detection methodologies are particularly useful in the case of slow-growing organisms, such as Legionella species. If these molecular methods are demonstrated to be as sensitive as culture, then culture should not be required to confirm negative molecular test results. If an organism has a predictable antimicrobial susceptibility profile, the need to cultivate the organism may be also obviated. However, if DNA fingerprinting by pulsed-field gel electrophoresis of genomic DNA is required for epidemiological purposes, then the organism must be cultured. As a precaution, one may attempt to culture all specimens which are positive by LC-PCR, with the cultures to be used in the event that further studies (antimicrobial susceptibility or DNA fingerprinting) are needed.
With respect to detection of Legionella in tissue, it is probable that further optimization of extraction methods would increase the sensitivity of LC-PCR. Based on the limited number of specimens included in this study, the ISH method we used was a more accurate means than LC-PCR for detection of L. pneumophila in tissue. ISH offers a faster turnaround time for results than culture. Also of benefit, compared both to culture and to PCR, ISH preserves tissue morphology and requires only a 4-µm-thick tissue section. This might be of particular benefit in the instances in which limited biopsy material is available for culture or for PCR assays. The primary drawback to the ISH assay that we used is that its detection is limited to L. pneumophila; however, the development of additional ISH probes could remedy this problem. Both ISH and PCR offer the advantage over culture of using formalin-fixed tissue. This allows retrospective study when culture results are not available or when fresh tissue is unavailable for culture, either due to quantitative limitations or because Legionella may not have been a diagnostic consideration at the time of biopsy.
The reported sensitivity of L. pneumophila serogroup 1 polysaccharide urinary antigen determination in active cases of disease has ranged from 55 to 90% (8-10, 25, 48, 56). For the present study, the sensitivity of L. pneumophila species-specific LC-PCR was 100%; with open lung biopsies, the sensitivity of L. pneumophila species-specific ISH was 100%. As we did not perform L. pneumophila urinary antigen assays of samples from these patients, we cannot effectively deduce what the sensitivity of the antigen assay would be. Therefore, the utility of urinary antigen assays in our patients is undetermined.
The availability of real-time PCR offers the potential for dramatically increasing the speed with which legionellosis can be diagnosed. PCR appears equal to culture in sensitivity and specificity for BAL specimens. The use of real-time PCR offers advantages over conventional amplification methods, including an easily performed test, procedure, a marked decrease in turnaround time for results, and a reduction in the risk of cross-contamination. These factors should make this technology adaptable for routine use in the clinical laboratory.
While a prospective study is needed to prove the clinical value of the LC-PCR assay described herein, it appears suitable as a first-line assay for the detection of Legionella species in BAL specimens. Samples positive by PCR could be cultured in order to allow for supplemental studies (i.e., epidemiologic investigations or antimicrobial susceptibility testing). In contrast, considering the assays we evaluated, culture was the best method for detecting Legionella species in lung tissue. WS staining, Legionella genus LC-PCR, and L. pneumophila-specific ISH were useful as rapid tests.
| |
ACKNOWLEDGMENT |
|---|
Roberta Kondert is thanked for her effort in preparing the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Clinical Microbiology, Department of Pathology and Laboratory Medicine, Hilton Building, Mayo Clinic, 200 First St., S.W., Rochester, MN 55905. Phone: (507) 284-2901. Fax: (507) 284-4272. E-mail: cockerill.franklin{at}mayo.edu.
Present address: St. Jude Children's Research Hospital, Memphis, Tennessee.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bej, A. K., M. H. Mahbubani, R. Miller, J. L. DiCesare, L. Haff, and R. M. Atlas. 1990. Multiplex PCR amplification and immobilized capture probes for detection of bacterial pathogens and indicators in water. Mol. Cell. Probes 4:353-365[CrossRef][Medline]. |
| 2. | Benson, R. F., and B. S. Fields. 1998. Classification of the genus Legionella. Semin. Respir. Infect. 13:90-99[Medline]. |
| 3. | Blackmon, J. A., F. W. Chandler, and M. D. Hicklin. 1979. Legionnaires' disease: a review for pathologists. Pathol. Annu. 14:383-404. |
| 4. | Chandler, F. W., M. D. Hicklin, and J. A. Blackmon. 1977. Demonstration of the agent of Legionnaires' disease in tissue. N. Engl. J. Med. 297:1218-1220[Medline]. |
| 5. |
Cherry, W. B.,
B. Pittman,
P. P. Harris,
G. A. Hebert,
B. M. Thomason,
L. Thacker, and R. E. Weaver.
1978.
Detection of Legionnaires disease bacteria by direct immunofluorescent staining.
J. Clin. Microbiol.
8:329-338 |
| 6. |
Cloud, J. L.,
K. C. Carroll,
P. Pixton,
M. Erali, and D. R. Hillyard.
2000.
Detection of Legionella species in respiratory specimens using PCR with sequencing confirmation.
J. Clin. Microbiol.
38:1709-1712 |
| 7. | Doern, G. V. 2000. Detection of selected fastidious bacteria. Clin. Infect. Dis. 30:166-173[CrossRef][Medline]. |
| 8. |
Domínguez, J. A.,
N. Galí,
P. Pedroso,
A. Fargas,
E. Padilla,
J. M. Manterola, and L. Matas.
1998.
Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the Biotest Legionella Urin Antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples.
J. Clin. Microbiol.
36:2718-2722 |
| 9. | Dominguez, J. A., J. M. Manterola, R. Blavia, N. Sopena, F. J. Belda, E. Padilla, M. Gimenez, M. Sabria, J. Morera, and V. Ausina. 1996. Detection of Legionella pneumophila serogroup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration. J. Clin. Microbiol. 34:2334-2336[Abstract]. |
| 10. | Dominguez, J. A., L. Matas, J. M. Manterola, R. Blavia, N. Sopena, F. J. Belda, E. Padilla, M. Gimenez, M. Sabria, J. Morera, and V. Ausina. 1997. Comparison of radioimmunoassay and enzyme immunoassay kits for detection of Legionella pneumophila serogroup 1 antigen in both concentrated and nonconcentrated urine samples. J. Clin. Microbiol. 35:1627-1629[Abstract]. |
| 11. | Edelstein, P. H. 1987. The laboratory diagnosis of Legionnaires' disease. Semin. Respir. Infect. 2:235-241[Medline]. |
| 12. |
Edelstein, P. H.,
K. B. Beer,
J. C. Sturge,
A. J. Watson, and L. C. Goldstein.
1985.
Clinical utility of a monoclonal direct fluorescent reagent specific for Legionella pneumophila: comparative study with other reagents.
J. Clin. Microbiol.
22:419-421 |
| 13. |
Edelstein, P. H.,
R. N. Bryan,
R. K. Enns,
D. E. Kohne, and D. L. Kacian.
1987.
Retrospective study of Gen-Probe rapid diagnostic system for detection of legionellae in frozen clinical respiratory tract samples.
J. Clin. Microbiol.
25:1022-1026 |
| 14. | Engleberg, N. C., C. Carter, P. Demarsh, D. J. Drutz, and B. I. Eisenstein. 1986. A Legionella-specific DNA probe detects organisms in lung tissue homogenates from intranasally inoculated mice. Isr. J. Med. Sci. 22:703-705[Medline]. |
| 15. |
Espy, M. J.,
J. R. Uhl,
P. S. Mitchell,
J. N. Thorvilson,
K. A. Svien,
A. D. Wold, and T. F. Smith.
2000.
Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR.
J. Clin. Microbiol.
38:795-799 |
| 16. | Fain, J. S., R. N. Bryan, L. Cheng, K. J. Lewin, D. D. Porter, and W. W. Grody. 1991. Rapid diagnosis of Legionella infection by a nonisotopic in situ hybridization method. Am. J. Clin. Pathol. 95:719-724[Medline]. |
| 17. | Fang, G. D., V. L. Yu, and R. M. Vickers. 1989. Disease due to the Legionellaceae (other than Legionella pneumophila). Historical, microbiological, clinical, and epidemiological review. Medicine (Baltimore) 68:116-132[Medline]. (Erratum, 68:209.) |
| 18. | Finkelstein, R., P. Brown, W. A. Palutke, B. B. Wentworth, J. G. Geiger, G. D. Bostic, and J. D. Sobel. 1993. Diagnostic efficacy of a DNA probe in pneumonia caused by Legionella species. J. Med. Microbiol. 38:183-186[Abstract]. |
| 19. |
Grimm, D.,
H. Merkert,
W. Ludwig,
K. H. Schleifer,
J. Hacker, and B. C. Brand.
1998.
Specific detection of Legionella pneumophila: construction of a new 16S rRNA-targeted oligonucleotide probe.
Appl. Environ. Microbiol.
64:2686-2690 |
| 20. |
Grimont, P. A.
1986.
Rapid methods for identification of Legionella a review.
Isr. J. Med. Sci.
22:697-702[Medline].
|
| 21. | Helbig, J. H., J. B. Kurtz, M. C. Pastoris, C. Pelaz, and P. C. Luck. 1997. Antigenic lipopolysaccharide components of Legionella pneumophila recognized by monoclonal antibodies: possibilities and limitations for division of the species into serogroups. J. Clin. Microbiol. 35:2841-2845[Abstract]. |
| 22. |
Jaulhac, B.,
M. Nowicki,
N. Bornstein,
O. Meunier,
G. Prevost,
Y. Piemont,
J. Fleurette, and H. Monteil.
1992.
Detection of Legionella spp. in bronchoalveolar lavage fluids by DNA amplification.
J. Clin. Microbiol.
30:920-924 |
| 23. | Johnson, J. L. 1994. Similarity analysis of rRNAs, p. 683-700. In P. Gerhardt, R. G. E. Murray, W. A. Wood, and N. R. Krieg (ed.), Methods for general and molecular bacteriology. American Society for Microbiology, Washington, D.C. |
| 24. | Jonas, D., A. Rosenbaum, S. Weyrich, and S. Bhakdi. 1995. Enzyme-linked immunoassay for detection of PCR-amplified DNA of legionellae in bronchoalveolar fluid. J. Clin. Microbiol. 33:1247-1252[Abstract]. |
| 25. | Kashuba, A. D., and C. H. Ballow. 1996. Legionella urinary antigen testing: potential impact on diagnosis and antibiotic therapy. Diagn. Microbiol. Infect. Dis. 24:129-139[CrossRef][Medline]. |
| 26. |
Ke, D.,
C. Menard,
F. J. Picard,
M. Boissinot,
M. Ouellette,
P. H. Roy, and M. G. Bergeron.
2000.
Development of conventional and real-time PCR assays for the rapid detection of group B streptococci.
Clin. Chem.
46:324-331 |
| 27. |
Kessler, H. H.,
F. F. Reinthaler,
A. Pschaid,
K. Pierer,
B. Kleinhappl,
E. Eber, and E. Marth.
1993.
Rapid detection of Legionella species in bronchoalveolar lavage fluids with the EnviroAmp Legionella PCR amplification and detection kit.
J. Clin. Microbiol.
31:3325-3328 |
| 28. | Koide, M., and A. Saito. 1995. Diagnosis of Legionella pneumophila infection by polymerase chain reaction. Clin. Infect. Dis. 21:199-201[Medline]. |
| 29. | Koide, M., A. Saito, N. Kusano, M. Tateyama, J. Inadome, Y. Kyan, T. Kishaba, and S. Miyagi. 1996. Relation between the polymerase chain reaction and the indirect fluorescent antibody method in the diagnosis of Legionella infection. Clin. Infect. Dis. 23:656-657[Medline]. |
| 30. | Koneman, E. W., S. D. Allen, W. M. Janda, P. C. Schreckenberger, and W. C. Winn (ed.). Color atlas and textbook of diagnostic microbiology. 5th ed., p. 473-489. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 31. | Lee, M. A., G. Brightwell, D. Leslie, H. Bird, and A. Hamilton. 1999. Fluorescent detection techniques for real-time multiplex strand specific detection of Bacillus anthracis using rapid PCR. J. Appl. Microbiol. 87:218-223[CrossRef][Medline]. |
| 32. |
Lindsay, D. S.,
W. H. Abraham, and R. J. Fallon.
1994.
Detection of mip gene by PCR for diagnosis of Legionnaires' disease.
J. Clin. Microbiol.
32:3068-3069 |
| 33. | Lisby, G., and R. Dessau. 1994. Construction of a DNA amplification assay for detection of Legionella species in clinical samples. Eur. J. Clin. Microbiol. Infect. Dis. 13:225-231[CrossRef][Medline]. |
| 34. | Lloyd, R. V., and L. Jin. 1995. In situ hybridization analysis of chromogranin A and B mRNAs in neuroendocrine tumors with digoxigenin-labeled oligonucleotide probe cocktails. Diagn. Mol. Pathol. 4:143-151[Medline]. |
| 35. | Mahbubani, M. H., A. K. Bej, R. Miller, L. Haff, J. DiCesare, and R. M. Atlas. 1990. Detection of Legionella with polymerase chain reaction and gene probe methods. Mol. Cell. Probes 4:175-187[CrossRef][Medline]. |
| 36. | Maiwald, M., M. Schill, C. Stockinger, J. H. Helbig, P. C. Luck, W. Witzleb, and H. G. Sonntag. 1995. Detection of Legionella DNA in human and guinea pig urine samples by the polymerase chain reaction. Eur. J. Clin. Microbiol. Infect. Dis. 14:25-33[CrossRef][Medline]. |
| 37. |
Matsiota-Bernard, P.,
E. Pitsouni,
N. Legakis, and C. Nauciel.
1994.
Evaluation of commercial amplification kit for detection of Legionella pneumophila in clinical specimens.
J. Clin. Microbiol.
32:1503-1505 |
| 38. |
Menendez, R.,
J. Cordoba,
P. de La Cuadra,
M. J. Cremades,
J. L. Lopez-Hontagas,
M. Salavert, and M. Gobernado.
1999.
Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia.
Am. J. Respir. Crit. Care Med.
159:1868-1873 |
| 39. | Mikel, U. V. 1994. Advanced laboratory methods in histology and pathology. American Registry of Pathology, Washington, D.C. |
| 40. | Miyamoto, H., H. Yamamoto, K. Arima, J. Fujii, K. Maruta, K. Izu, T. Shiomori, and S. Yoshida. 1997. Development of a new seminested PCR method for detection of Legionella species and its application to surveillance of legionellae in hospital cooling tower water. Appl. Environ. Microbiol. 63:2489-2494[Abstract]. |
| 41. | Munder, R. U. 2000. Other Legionella Species, p. 2435-2441. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 5th ed., vol. 2. Churchill Livingstone, Philadelphia, Pa. |
| 42. | Murdoch, D. R., E. J. Walford, L. C. Jennings, G. J. Light, M. I. Schousboe, A. Y. Chereshsky, S. T. Chambers, and G. I. Town. 1996. Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia. Clin. Infect. Dis. 23:475-480[Medline]. |
| 43. | Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.). 1999. Manual of clinical microbiology, 5th ed. ASM Press, Washington, D.C. |
| 44. |
Nitsche, A.,
N. Steuer,
C. A. Schmidt,
O. Landt, and W. Siegert.
1999.
Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA.
Clin. Chem.
45:1932-1937 |
| 45. |
Pasculle, A. W.,
G. E. Veto,
S. Krystofiak,
K. McKelvey, and K. Vrsalovic.
1989.
Laboratory and clinical evaluation of a commercial DNA probe for the detection of Legionella spp.
J. Clin. Microbiol.
27:2350-2358 |
| 46. | Ramirez, J. A., S. Ahkee, A. Tolentino, R. D. Miller, and J. T. Summersgill. 1996. Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen. Diagn. Microbiol. Infect. Dis. 24:7-14[CrossRef][Medline]. |
| 47. | Reingold, A. L., B. M. Thomason, B. J. Brake, L. Thacker, H. W. Wilkinson, and J. N. Kuritsky. 1984. Legionella pneumonia in the United States: the distribution of serogroups and species causing human illness. J. Infect. Dis. 149:819[Medline]. |
| 48. | Sathapatayavongs, B., R. B. Kohler, L. J. Wheat, A. White, and W. C. Winn, Jr. 1983. Rapid diagnosis of Legionnaires' disease by latex agglutination. Am. Rev. Respir. Dis. 127:559-562[Medline]. |
| 49. |
Starnbach, M. N.,
S. Falkow, and L. S. Tompkins.
1989.
Species-specific detection of Legionella pneumophila in water by DNA amplification and hybridization.
J. Clin. Microbiol.
27:1257-1261 |
| 50. | Suffin, S. C., A. F. Kaufmann, B. Whitaker, K. B. Muck, G. A. Prince, and D. D. Porter. 1980. Legionella pneumophila: identification in tissue sections by a new immunoenzymatic procedure. Arch. Pathol. Lab. Med. 104:283-286[Medline]. |
| 51. |
Theaker, J. M.,
J. O. Tobin,
S. E. Jones,
P. Kirkpatrick,
M. I. Vina, and K. A. Fleming.
1987.
Immunohistological detection of Legionella pneumophila in lung sections.
J. Clin. Pathol.
40:143-146 |
| 52. |
Thomason, B. M.,
A. Van Orden,
F. W. Chandler, and M. D. Hicklin.
1979.
Effect of various histological fixatives on fluorescent antibody detection of Legionnaires disease bacteria.
J. Clin. Microbiol.
10:106-108 |
| 53. | Weir, S. C., S. H. Fischer, F. Stock, and V. J. Gill. 1998. Detection of Legionella by PCR in respiratory specimens using a commercially available kit. Am. J. Clin. Pathol. 110:295-300[Medline]. |
| 54. | Whitcombe, D., C. R. Newton, and S. Little. 1998. Advances in approaches to DNA-based diagnostics. Curr. Opin. Biotechnol. 9:602-608[CrossRef][Medline]. |
| 55. |
Wilkinson, H. W.,
J. S. Sampson, and B. B. Plikaytis.
1986.
Evaluation of a commercial gene probe for identification of Legionella cultures.
J. Clin. Microbiol.
23:217-220 |
| 56. | Winn, W. C. 1999. Legionella, p. 572-585. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology. ASM Press, Washington, D.C. |
| 57. | Wittwer, C. T., M. G. Herrmann, A. A. Moss, and R. P. Rasmussen. 1997. Continuous fluorescence monitoring of rapid cycle DNA amplification. BioTechniques 22:130-131[Medline], 134-138. |
| 58. | Wittwer, C. T., K. M. Ririe, R. V. Andrew, D. A. David, R. A. Gundry, and U. J. Balis. 1997. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. BioTechniques 22:176-181[Medline]. |
| 59. | Woo, T. H., B. K. Patel, L. D. Smythe, M. L. Symonds, M. A. Norris, R. S. Weyant, and M. F. Dohnt. 1998. Identification of Leptospira inadai by continuous monitoring of fluorescence during rapid cycle PCR. Syst. Appl. Microbiol. 21:89-96[Medline]. |
| 60. | Yu, V. L. 2000. Legionella pneumophila, p. 2424-2435. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 5th ed., vol. 2. Churchill Livingstone, Philadelphia, Pa. |
| 61. | Zuravleff, J. J., V. L. Yu, J. W. Shonnard, B. K. Davis, and J. D. Rihs. 1983. Diagnosis of Legionnaires' disease. An update of laboratory methods with new emphasis on isolation by culture. JAMA 250:1981-1985[Abstract]. |
This article has been cited by other articles:
| ||||||||||